Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

Editorial: Improving efficacy and expanding the reach of T-cell therapeutics for solid tumors: an end-to-end perspective

  1. 1BioNTech US, Inc.
  2. 2AstraZeneca
  3. 3Earle A. Chiles Research Institute, a division of Providence Cancer Institute

Related

  1. Editorial: Expanding the therapeutic dose range of cannabinoid-based therapy
    Joshua S. Kaplan, Luzia S. Sampaio, Raquel M. P. Campos +1
    Frontiers in NeurosciencePeer-reviewedCC BY 4.0NeuroscienceCrossref
  2. Editorial: The expanding spectrum of hemophagocytic lymphohistiocytosis: pathogenic mechanisms and therapeutic implications
    Tiziana Lorenzini, Ola Sabet, Yasmine El Chazli +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossref
  3. Editorial: Evolution of antimicrobial resistance in intracellular bacterial pathogens: a genomic and historical perspective
    Kumaragurubaran Karthik, Maryam Dadar, Subbaiyan Anbazhagan +1
    Frontiers in MicrobiologyPeer-reviewedCC BY 4.0Full textMicrobiologyHAL
  4. Improving allergic rhinitis symptoms through nutrition as an adjunct: a systematic review and meta-analysis on the efficacy of dietary supplements
    Jun Jie Lim, Ying Xin Lee, Qi Yi Ambrose Wong +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textImmunologyCrossref
  5. Efficacy of statistical and design interventions for improving reproducibility in biomedical research
    Bernhard Voelkl, Rachel Heyard, Laura Caquelin +3
    BMC BiologyPeer-reviewedCC BY 4.0Molecular biology & gene regulationGeneral biologyCrossref
BibTeX
@article{juneja2026editorial,
  title = {{Editorial: Improving efficacy and expanding the reach of T-cell therapeutics for solid tumors: an end-to-end perspective}},
  author = {Vikram R. Juneja and Gavin M. Bendle and Eric Tran and Marit M. van Buuren},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = nov,
  doi = {10.3389/fimmu.2026.2038020},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.2038020/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Editorial: Improving efficacy and expanding the reach of T-cell therapeutics for solid tumors: an end-to-end perspective
AU  - Vikram R. Juneja
AU  - Gavin M. Bendle
AU  - Eric Tran
AU  - Marit M. van Buuren
PY  - 2026
DA  - 2026/11/16
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.2038020
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.2038020/full
SN  - 1664-3224
ER  -